Key facts
- Notable investors include African Union Development Agency-NEPAD, Talanton.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Pharmakina
- ·The full record, as it builds
Funding rounds
No funding rounds for Pharmakina are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pharmakina
Provider of a pharmaceutical company intended for the plantation of cinchona. The company transforms its own quinine salts into finished pharmaceutical products, offering them as Active Pharmaceutical Ingredients (API) for export and as Finished Pharmaceutical Products (FPP) for the Democratic Republic of Congo and regional markets, enabling consumers with healthcare and life-saving treatments.
- Sector
- Healthcare
- HQ
- Bukavu, Congo
- Founded
- 1961
- Website
- pharmakina.com/
- Ownership
- Privately Held (backing)
Pharmakina doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pharmakina shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pharmakina in its N-PORT filings yet. We sweep new filings monthly.